Recombinant therapeutic proteins - A success story

Translated title of the contribution: Recombinant therapeutic proteins - A success story

Karsten Schürrle, Arne Skerra

Research output: Contribution to journalArticlepeer-review


After a first decade of using recombinant versions of natural proteins, novel engineered biologics have complemented the arsenal of medicine during the last 20 years. Today, tailor-made hormones, enzymes and fusion proteins offer optimised pharmacokinetic properties and new modes of action. Beside human(ized) antibodies, engineered protein scaffolds have recently entered the pharmaceutical R&D pipeline and open prospects for the specific targeting of diverse disease targets especially in the areas of oncology and inflammation.

Translated title of the contributionRecombinant therapeutic proteins - A success story
Original languageEnglish
Pages (from-to)36-38
Number of pages3
Issue number1
StatePublished - Feb 2015


Dive into the research topics of 'Recombinant therapeutic proteins - A success story'. Together they form a unique fingerprint.

Cite this